Jiangsu Bioperfectus Technologies Co., Ltd.

XSSC:688399 Stock Report

Market Cap: CN¥3.8b

Jiangsu Bioperfectus Technologies Past Earnings Performance

Past criteria checks 0/6

Jiangsu Bioperfectus Technologies has been growing earnings at an average annual rate of 3.2%, while the Medical Equipment industry saw earnings growing at 6.5% annually. Revenues have been declining at an average rate of 19.5% per year.

Key information

3.2%

Earnings growth rate

2.3%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate-19.5%
Return on equity-9.1%
Net Margin-78.5%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Jiangsu Bioperfectus Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:688399 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24400-314386121
31 Dec 23403-374407135
30 Sep 231,51828513116
30 Jun 232,455526493149
31 Mar 234,1071,177629192
31 Dec 225,5351,828779185
30 Sep 224,9611,821705213
30 Jun 224,9741,925738176
31 Mar 223,5041,437592117
31 Dec 212,8391,193547106
30 Sep 212,8111,23453689
30 Jun 212,2981,01449081
31 Mar 212,3961,10348675
31 Dec 201,74082037370
30 Sep 201,19961622956
30 Jun 2073936117647
31 Mar 2043617414542
31 Dec 192898411437
30 Sep 192637418450
31 Dec 182316410326
31 Dec 17187439321
31 Dec 1612988614

Quality Earnings: 688399 is currently unprofitable.

Growing Profit Margin: 688399 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688399 is unprofitable, but has reduced losses over the past 5 years at a rate of 3.2% per year.

Accelerating Growth: Unable to compare 688399's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 688399 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.09%).


Return on Equity

High ROE: 688399 has a negative Return on Equity (-9.12%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.